Search by Drug Name or NDC

    NDC 63323-0539-13 Enoxaparin Sodium 300 mg/3mL Details

    Enoxaparin Sodium 300 mg/3mL

    Enoxaparin Sodium is a INTRAVENOUS; SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ENOXAPARIN SODIUM.

    Product Information

    NDC 63323-0539
    Product ID 63323-539_f1604264-1625-131c-e053-2a95a90a897c
    Associated GPIs 83101020102050
    GCN Sequence Number 038895
    GCN Sequence Number Description enoxaparin sodium VIAL 300 MG/3ML SUBCUT
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 96334
    HICL Sequence Number 007878
    HICL Sequence Number Description ENOXAPARIN SODIUM
    Brand/Generic Generic
    Proprietary Name Enoxaparin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name enoxaparin sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 300
    Active Ingredient Units mg/3mL
    Substance Name ENOXAPARIN SODIUM
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA020164
    Listing Certified Through 2024-12-31

    Package

    NDC 63323-0539-13 (63323053913)

    NDC Package Code 63323-539-13
    Billing NDC 63323053913
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (63323-539-13) / 3 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2019-06-18
    NDC Exclude Flag N
    Pricing Information N/A